Emergency Department Acupuncture for Acute Musculoskeletal Pain Management
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04290741 |
Recruitment Status :
Enrolling by invitation
First Posted : March 2, 2020
Last Update Posted : March 9, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this project is to determine the feasibility, acceptability and effectiveness of acupuncture in the Emergency Department (ED) for treating acute musculoskeletal pain. The overall goal is to reduce acute and subacute opioid use by improving acute pain, anxiety and disability with non-pharmacologic treatment options at a critical entry point for patients into the healthcare system. This full-scale randomized controlled trial (RCT) has been statistically powered to test the effectiveness of ED-based acupuncture for both one-hour (Stage 1) and one-month (Stage 2) pain reduction outcomes. The feasibility will be assessed based on patient recruitment and retention rates, while the acceptability will be assessed using patient reported outcomes and qualitative semi-structured interviews.
Stage 1 is a 2-phase study design. Phase (1): Enrolled subjects will be randomized to auricular (ear) acupuncture, peripheral acupuncture, or the control group receiving no acupuncture. Subjects assigned to an acupuncture arm will receive information and access to acupuncture in an outpatient clinic for the 4 weeks following ED visit. Subjects may also have a blood draw for biomarker analysis during their ED visit. A planned interim analysis of the first 60 patients (2/3 of the Phase 1 arm completed) will be completed to select the more effective and/or acceptable arm for Phase 2. At interim analysis, it was determined by the DSMB that neither arm was superior, so the recommendation was to continue Stage 1 Phase 2 unchanged with 3 arms. Stage 1 is complete, and we will proceed with Stage 2 powered to the 4-week pain score outcome. Stage 2 will proceed with the same procedures as stage 1, only powered to a different outcome.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Musculoskeletal Pain | Procedure: Auricular (Battlefield) Acupuncture Procedure: Peripheral Acupuncture | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 750 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Emergency Department Acupuncture for Acute Musculoskeletal Pain Management |
Actual Study Start Date : | February 10, 2020 |
Estimated Primary Completion Date : | April 15, 2023 |
Estimated Study Completion Date : | June 15, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Auricular (Battlefield) Acupuncture
Auricular acupuncture involves placement of needles based on battlefield acupuncture protocol which involves the placement of needles in up to 5 sites on each ear to treat pain.
|
Procedure: Auricular (Battlefield) Acupuncture
Placement of needles based on battlefield acupuncture protocol which includes up to 5 sites on each ear to treat pain. |
Experimental: Peripheral Acupuncture
Peripheral acupuncture involves placement of needles in up to 30 specific sites in the head, neck, arms from the shoulders to the hands, and legs from the knees to the feet
|
Procedure: Peripheral Acupuncture
Placement of needles in up to 30 specific sites in the head, neck, arms from the shoulders to the hands, and legs from the knees to the feet |
No Intervention: Control
Standard of care without acupuncture
|
- Change in Pain Score [ Time Frame: ED pre-acupuncture (baseline); ED post-acupuncture (up to 1 hour); 2 and 4 weeks post discharge ]11-point Numeric Rating Scale (NRS) for current pain
- Number of ED patients eligible for recruitment as measured by patient log [ Time Frame: Post implementation, up to 6 weeks ]
- Number of patients enrolled as measured by patient log [ Time Frame: Post implementation, up to 6 weeks ]
- Number of patients retained in study as measured by patient log [ Time Frame: Post implementation, up to 6 weeks ]
- Number of patients that found acupuncture satisfactory via satisfactory questionnaire [ Time Frame: Post implementation, up to 6 weeks ]Likert-scale, agree disagree
- Number of outpatient acupuncture sessions attended [ Time Frame: 4 weeks post discharge ]
- Number of adverse events [ Time Frame: Post implementation, up to 2 weeks ]
- Change in function [ Time Frame: ED pre-acupuncture (baseline); ED post-acupuncture (up to 1 hour); 2 and 4 weeks post discharge ]PROMIS-29
- Change in cognitive function [ Time Frame: ED pre-acupuncture (baseline); ED post-acupuncture (up to 1 hour); 2 and 4 weeks post discharge ]Neuro-QoL
- Number of return ED visits [ Time Frame: Up to one year post ED visit ]
- Pain medications received [ Time Frame: Up to three months post ED visit ]
- Time in minutes for ED based acupuncture session [ Time Frame: Post ED acupuncture session, up to 1 hour ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Adults age 18 or older
- Clinical diagnosis of acute (≤7 days) musculoskeletal pain as determined by an ED provider
- Able to read and understand the consent form in English
Exclusion Criteria:
- Unable to receive acupuncture due to injury or infection of acupuncture sites
- Unwilling or unable to attend the follow-up outpatient acupuncture clinic
- Severe hearing or speech impairment
- Cognitive impairment, including evidence of drug, medication or alcohol intoxication, that would prevent comprehension of consent procedures or study measures and procedures
- Critical illness
- Deformity
- Medical condition that would contraindicate safe participation as determine by an ED provider

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04290741
United States, North Carolina | |
Duke University Hospital Emergency Department | |
Durham, North Carolina, United States, 27710 |
Principal Investigator: | Stephanie Eucker, MD, PhD | Duke University |
Responsible Party: | Duke University |
ClinicalTrials.gov Identifier: | NCT04290741 |
Other Study ID Numbers: |
Pro00104140 |
First Posted: | March 2, 2020 Key Record Dates |
Last Update Posted: | March 9, 2023 |
Last Verified: | March 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Acupuncture Pain Emergency Department |
Musculoskeletal Pain Emergencies Disease Attributes Pathologic Processes |
Muscular Diseases Musculoskeletal Diseases Pain Neurologic Manifestations |